The Group's principal activity is to discover, develop, manufacture and market advanced drug therapies to meet medical needs. It operates through three reportable segments: Prescription Pharmaceuticals segment discovers, develops, manufactures and markets human pharmaceutical products. Animal Health segment discovers, develops, manufactures and markets animal health products. Consumer Health Care segment develops, manufactures and markets OTC, foot care and sun care products. It operates in Europe, Canada, Latin America, Asia Pacific.
Alacra Alerts:
Receive alerts on the latest reports on Schering-Plough Corporation
Subscribe to Alacra Alerts via RSS and never miss the latest research on your favorite companies. Just click the images above to add the feed directly to your favorite newsreader.
